+987.9%
MRNA vs FLNC
-69.0%
+1,056.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FLNC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +10.2% | +2.9% | +11.2% |
| 7D | +20.6% | -2.1% | +22.7% | +21.0% |
| 30D | +27.1% | -20.8% | +47.9% | +32.0% |
| 3M | +353.4% | -61.3% | +414.7% | +427.3% |
| 6M | +446.3% | -50.9% | +497.1% | +486.4% |
| YTD | +776.2% | -69.4% | +845.5% | +890.4% |
| 1Y | +987.9% | -68.4% | +1,056.3% | +1,105.9% |
| All | +987.9% | -69.0% | +1,056.9% | +1,105.9% |
Cumulative growth
Daily Returns
Daily percentage return beside FLNC.
Daily Out/Under-Performance
Portfolio return minus FLNC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FLNC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FLNC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling